	Stanolone-1,2,3-Triazole derivatives: Synthesis, DNA damage in tumor cells and anti-prostate Cancer activity study. Bioorg Med Chem Lett Hou X, Xu S, Mao L, Li YM, Wang J. PMID: 40953680 [PubMed - as supplied by publisher]
	A bioinformatics screen identifies TCF19 as an aggressiveness-sustaining gene in prostate cancer. Mol Oncol Ercilla A, Crespo JR, Garcia-Longarte S, Fidalgo M, Del Palacio S, Martin-Martin N, Carlevaris O, Astobiza I, Fernández-Ruiz S, Guiu M, Bárcena L, Mendizabal I, Aransay AM, Graupera M, Gomis RR, Carracedo A. PMID: 40952912 [PubMed - as supplied by publisher]
	Tackling the Cardio-Kidney-Metabolic Burden in Cancer. Curr Atheroscler Rep Nahle T, Shah V, Kunhiraman HH, Makram OM, Ahmed O, Yerraguntla S, Gopu G, Vy J, Singh S, Borse T, Kalinsky K, Deswal A, Sadler D, Chitalia V, Weintraub NL, Guha A. PMID: 40952628 [PubMed - in process]
	[Retroperitoneal lymphadenectomy (RPLND) for the treatment of testicular germ cell tumors-open or robotic? Pro open surgery : RPLND in the management of testis cancer]. Urologie Heidenreich A, Pfister D. PMID: 40952481 [PubMed - as supplied by publisher]
	Lifestyle-Related Factors and Dietary Components that Affect the Risk of Prostate Cancer in a Brazilian Study Group. Asian Pac J Cancer Prev Silva IAD, Weller M. PMID: 40952283 [PubMed - in process]
	Quality of Life in Prostate Cancer Patients Following Radical Prostatectomy: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev Seputra KP, Daryanto B, Budaya TN, Satyagraha P, Purnomo AF, Rofifa AF, Dhani FK. PMID: 40952272 [PubMed - in process]
	Effects of doxazosin as adjuvant to abiraterone on viability and apoptosis of metastatic castration-resistant prostate cells cancer (mCRPC) PC3. Narra J Pratama PK, Rahman ZA, Hidayatullah F, Laksita TB, Hakim L. PMID: 40951478 [PubMed - in process]
	Comparing the safety and efficacy of systemic therapies for high-risk biochemically recurrent hormone-sensitive prostate cancer: a network meta-analysis. Front Oncol Aprikian A, Chilelli A, McLean T, Nasr A, Ganguli A, Serikoff A, Guzman F, Barouma I, Zacharioudaki M, Freedland SJ. PMID: 40951348 [PubMed]
	Management of Locally Advanced Prostate Cancer: A Scoping Review of Contemporary Evidence and Emerging Approaches. Cureus Adefehinti M, George AO, Enemoh O, Adenipekun B, Akinwale M, Akintayo A, Sanni QA, Adebisi AA, Erewele E, Onipede O, Oore-Ofe O, Ibikunle TP, Ajani OO. PMID: 40951035 [PubMed]
	A Multifactorial Case of Retroperitoneal Fibrosis in a Post-radiation Bladder Cancer Patient: Diagnostic and Therapeutic Challenges. Cureus Shebani MAA, Ikdees AA, Alazeebi SY, Nagib E, Alagha HMK. PMID: 40951018 [PubMed]
	Alternating intravesical instillation of Bacillus Calmette-GuÃ©rin and Pseudomonas aeruginosa effectively prevents postoperative recurrence in high-risk non-muscle-invasive bladder cancer. Am J Transl Res Shao Y, Guan Y, Zhao J, Abudurexiti M, Wang Z. PMID: 40950259 [PubMed]
	Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profiling. bioRxiv Garinet S, Semaan K, Li J, Sadagopan A, Canniff J, Phillips N, Klega K, Panday M, Savignano H, Davidsohn MP, Lyons K, Medda A, Khanna P, Achom M, Konda P, Fortunato BJ, Nawfal R, Chehade REH, Zhang Z, O'Toole J, Horst J, Freeman D, Trowbridge R, Chau CH, Figg WD, Berchuck JE, Crompton BD, Seo JH, Choueiri TK, Freedman ML, Baca SC, Viswanathan SR. PMID: 40949957 [PubMed]
	How Advanced Are Extracellular Vesicles in Renal Cell Carcinoma? For Diagnostic and Therapeutic Frontiers. Int J Nanomedicine Zhou M, Wang L, Yu B, He J, Zhang J, Liu Z, Chen P, Ouyang C, Chen Z. PMID: 40949610 [PubMed - in process]
	Unlocking artificial intelligence, machine learning and deep learning to combat therapeutic resistance in metastatic castration-resistant prostate cancer: a comprehensive review. Ecancermedicalscience Ejaz ZH, Shaikh RH, Fatimi AS, Khan SR. PMID: 40949469 [PubMed]
	Diagnostic value and external validation of biparametric magnetic resonance imaging radiomics in clinically significant prostate cancer. Transl Androl Urol Xing H, Abudureheman Y, Ai X, Wang Y, Xu J, Huang C, Kelimu G, Li T. PMID: 40949443 [PubMed]
	Targeted prostate cancer screening using polygenic risk scores: lessons from the BARCODE1 trial. Transl Androl Urol Hennes D, Park H, Sathianathen N, Chen DC, Murphy DG, Perera ML. PMID: 40949438 [PubMed]
	Mechanisms, Clinical Trials, and New Treatments for BCG-Unresponsive in Nonmuscle Invasive Bladder Cancer. Cancer Med Huang X, Wang X, He Z, Huang Y, Hu B, Chen W, Du H. PMID: 40948378 [PubMed - in process]
	Ketone bodies and cancer risk in the general population: The prevention of renal and vascular end-stage disease (PREVEND) study. Eur J Clin Invest Luo L, Knol MGE, Kieneker LM, van der Vegt B, Bakker SJL, Gruppen EG, de Boer RA, Aboumsallem JP, Connelly MA, Dullaart RPF, Gansevoort RT. PMID: 40947948 [PubMed - in process]
	Critical Appraisal of "Impact and Risk Factors of Diagnostic Delay in Patients With Testicular Cancer: A Multicenter Retrospective Study". Int J Urol Majid A, Ahmed H, Khan V. PMID: 40947774 [PubMed - as supplied by publisher]
	Identifying potential therapeutic targets for prostate cancer with mediating role in tumor immunity. Discov Oncol Wu Z, Li S, Li Y, Wang Z, Wang W. PMID: 40947455 [PubMed]

Articles 1 - 20 / 170201

Page 1 of 8511



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy